Press Releases

Jun 03, 2021
Results of two new studies illustrate continued momentum for Dexcom CGM, including JAMA-published data on additional populations who can benefit from the technology SAN DIEGO --(BUSINESS WIRE)--Jun. 3, 2021-- DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring
May 27, 2021
SAN DIEGO --(BUSINESS WIRE)--May 27, 2021-- DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on Dexcom at the following upcoming investor conference: Jereme Sylvain , Executive Vice President and Chief Financial Officer, will present on behalf of the company at the
Apr 29, 2021
SAN DIEGO --(BUSINESS WIRE)--Apr. 29, 2021-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2021 . First Quarter 2021 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $505.0 million U.S.
Apr 07, 2021
Dexcom is now directly selling the Dexcom G6 Continuous Glucose Monitoring (CGM) System across the Netherlands Dexcom G6 CGM means no more fingersticks * for people with diabetes Real-time glucose data sent wirelessly to a compatible smart device † or Dexcom receiver Customisable alerts and alarms
Displaying 1 - 10 of 18